FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to novel compositions and using kahalalide F, to a set containing the kahalalide F composition and to a reduced solution prepared from the kahalalide F composition. Combination of non-ionic surface-active substance and organic acid is suitable for using with a filling agent for preparing lyophilized formulation of kahalalide F.
EFFECT: improved preparing method.
10 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL ANTITUMOR COMPOUNDS | 2003 |
|
RU2356908C2 |
| KAHALALIDE F DERIVATIVES | 2004 |
|
RU2395520C2 |
| TREATMENT OF MALIGNANT TUMOR WITH APLIDINE | 2000 |
|
RU2261104C2 |
| DRUG FOR TREATMENT OF BENIGN AND MALIGNANT TUMOR DISEASE COMPRISING DERIVATIVE OF DYSORAZOL | 2003 |
|
RU2322236C2 |
| DRUG EFFECTIVE FOR LYMPHOGENIC METHOD FOR THE INJECTION OF DRUG | 2017 |
|
RU2759640C2 |
| ANTINEOPLASTIC COMBINATIONS CONTAINING HKI-272 AND VINORELBINE | 2009 |
|
RU2492860C2 |
| COMPOSITION AND UTILIZATION OF ET743 FOR MALIGNANT TUMOR TREATMENT | 2000 |
|
RU2266734C2 |
| INTRAVESICAL APAZIQUONE INJECTION AFTER TRANSURETHRAL RESECTION FOR CANCER TREATMENT | 2012 |
|
RU2623142C2 |
| INTRODUCTION OF APAZIQUONE INTRAVESICAL AFTER TRANSURETHRAL RESECTION IN CANCER TREATMENT | 2008 |
|
RU2480200C2 |
| COMBINED APPLICATION OF ECTEINASCIDIN-743 AND PLATINUM-CONTAINING ANTI-TUMOUR COMPOUNDS | 2004 |
|
RU2391101C2 |
